Labcorp, Ultima Genomics collaborate to advance whole genome sequencing applications and oncology testing capabilities

Eric Green leaves his job as director of the NIH National Human Genome Research Institute

After serving as the director of the National Human Genome Research Institute for more than 15 years, Eric Green has left his role.

March 21, 2025

Vol.51 No.11

Clinical Trials & Tribulations

The new therapeutic imperative in cancer management: Sequence, biosimulate, treat

The definition of “therapeutic imperative” is this: A treatment necessity that must be met in order to prevent death. Once the imperative is clearly defined, addressing it properly links correct diagnosis with therapy and favorable prognosis. On the other hand, misdiagnosis or inadequate diagnosis fails to provide a framework for highly effective or curative therapy.

Felix Feng, GU cancer researcher who made fundamental discoveries in genomics, dies at 48

The University of California, San Francisco and global oncology communities mourn the death of Felix Y. Feng, MD, a radiation oncologist and a leading figure in genitourinary cancer research. A professor of radiation oncology, urology and medicine, and vice chair of translational research at the UCSF Helen Diller Family Comprehensive Cancer Center, Feng died from cancer on Dec.10, 2024. He was 48.

Felix Feng: “When a symposium is named after you, you can pretty much just wax poetic up on stage.”
Keynote address at The Feng Symposium in May 2024

On May 18, 2024, Felix Feng, a leader in genitourinary cancer research, gave the keynote address at the inaugural symposium that bears his name.

January 24, 2025

Vol.51 No.03

The Human Tumor Atlas Network charts the roadmap for advancing spatial omics

The NCI Human Tumor Atlas Network (HTAN) has published a cluster of papers intended to advance the framework of spatial omics, the science of profiling morphological and molecular features of human cancers in two and three dimensions.

FDA approves MI Cancer Seek as a CDx test for adults and pediatric patients

FDA has approved MI Cancer Seek for use as a companion diagnostic to identify patients with cancer who may benefit from treatment with targeted therapies.

November 08, 2024

Vol.50 No.42

Labcorp, Ultima Genomics collaborate to advance whole genome sequencing applications and oncology testing capabilities

YOU MAY BE INTERESTED IN

Eric Green leaves his job as director of the NIH National Human Genome Research Institute

The new therapeutic imperative in cancer management: Sequence, biosimulate, treat

Felix Feng, GU cancer researcher who made fundamental discoveries in genomics, dies at 48

Felix Feng: “When a symposium is named after you, you can pretty much just wax poetic up on stage.”
Keynote address at The Feng Symposium in May 2024

The Human Tumor Atlas Network charts the roadmap for advancing spatial omics

FDA approves MI Cancer Seek as a CDx test for adults and pediatric patients

Renew today!

Subscriber content

Never miss an issue!

Login

Labcorp, Ultima Genomics collaborate to advance whole genome sequencing applications and oncology testing capabilities

YOU MAY BE INTERESTED IN

Eric Green leaves his job as director of the NIH National Human Genome Research Institute

The new therapeutic imperative in cancer management: Sequence, biosimulate, treat

Felix Feng, GU cancer researcher who made fundamental discoveries in genomics, dies at 48

Felix Feng: “When a symposium is named after you, you can pretty much just wax poetic up on stage.”Keynote address at The Feng Symposium in May 2024

The Human Tumor Atlas Network charts the roadmap for advancing spatial omics

FDA approves MI Cancer Seek as a CDx test for adults and pediatric patients

Never miss an issue!

Login

Felix Feng: “When a symposium is named after you, you can pretty much just wax poetic up on stage.”
Keynote address at The Feng Symposium in May 2024